Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer

類似資料

• Upfront osimertinib in EGFR-mutated non-small cell lung cancer: is brain still a sanctuary?
  著者:: Leonetti, Alessandro, 等
  出版事項: (2018)
• Small Cell Lung Cancer Transformation as a Resistance Mechanism to Osimertinib in Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: Case Report and Literature Review
  著者:: Leonetti, Alessandro, 等
  出版事項: (2021)
• Dynamic Evaluation of Circulating miRNA Profile in EGFR-Mutated NSCLC Patients Treated with EGFR-TKIs
  著者:: Leonetti, Alessandro, 等
  出版事項: (2021)
• Third-generation epidermal growth factor receptor-tyrosine kinase inhibitors in T790M-positive non-small cell lung cancer: review on emerged mechanisms of resistance
  著者:: Minari, Roberta, 等
  出版事項: (2016)
• Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines
  著者:: La Monica, Silvia, 等
  出版事項: (2017)